“…Among 11 traditional Chinese medicines, obvious therapeutic effects of Chuanxiong, Bupleurum, Licorice, and Poria on stroke have been observed [ 22 ]. The active ingredients senkyunolide A, Z-ligustilide [ 16 ], Ligusticum, Ligustrazine, Ligustylid [ 23 ], ferulic acid, and Senkyunolide H [ 24 ] in Chuanxiong can dramatically inhibit the production of pro-inflammatory mediators in mouse BV-2 microglia after lipopolysaccharide (LPS) stimulation, obviously impair the aggregation of thrombosis and platelet, as well as blood viscosity to improve cerebral microcirculation, significantly reduce infarct volume, neurological dysfunction, BBB disruption, and cerebral edema [ 25 – 28 ]. The active ingredient Saikosaponin A in Bupleurum can significantly improve post-stroke depression (PSD)-like behavior, inhibit neuronal apoptosis, increased the levels of brain-derived neurotrophic factor and Bcl-2 in the hippocampus of PSD rats, and reduced the levels of Bax and caspase-3 [ 29 ].…”